XClose

UCL-TB

Home
Menu

2020 Publications

Go to Other Outputs

2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0. (2020) Ryom, L., A. Cotter, R. De Miguel, C. Beguelin, D. Podlekareva, J. R. Arribas, C. Marzolini, P. Mallon, A. Rauch, O. Kirk, J. M. Molina, G. Guaraldi, A. Winston, S. Bhagani, P. Cinque, J. D. Kowalska, S. Collins, M. Battegay and E. G. Board. HIV Med 21(10): 617-624 https://doi.org/10.1111/hiv.12878

Acceptability and feasibility of proposed control and prevention strategies for bovine tuberculosis among Ethiopian dairy farmers and associated professionals. (2020) Hodge, C., T. T. Deneke, M. A. Endalew, H. L. Moore and E. consortium. Prev Vet Med 185: 105184 https://doi.org/10.1016/j.prevetmed.2020.105184

Accuracy of Xpert Ultra in diagnosis of pulmonary tuberculosis among children in Uganda: a substudy from the SHINE trial. (2020) Ssengooba, W., J. D. Iragena, L. Nakiyingi, S. Mujumbi, E. Wobudeya, R. Mboizi, D. Boulware, D. B. Meya, L. Choo, A. M. Crook, K. Lebeau, M. Joloba, A. M. Demers, F. V. Cresswell and D. M. Gibb. J Clin Microbiol 58(9) https://doi.org/10.1128/JCM.00410-20

Advances in clinical trial design: Weaving tomorrow's TB treatments. (2020) Lienhardt, C., A. Nunn, R. Chaisson, A. A. Vernon, M. Zignol, P. Nahid, E. Delaporte and T. Kasaeva. PLoS Med 17(2): e1003059 https://doi.org/10.1371/journal.pmed.1003059

Advancing new diagnostic tests for latent tuberculosis infection due to multidrug-resistant strains of Mycobacterium tuberculosis - End of the road? (2020) Mwaba, P., J. M. Chakaya, E. Petersen, C. Wejse, A. Zumla and N. Kapata. Int J Infect Dis 92S: S69-S71 https://doi.org/10.1016/j.ijid.2020.02.011

Air-travel related TB incident follow up - effectiveness and outcomes: a systematic review. (2020) Maynard-Smith, L., C. S. Brown, R. J. Harris, P. Hodkinson, S. Tamne, S. R. Anderson and D. Zenner. Eur Respir J https://doi.org/10.1183/13993003.00013-2020

All nonadherence is equal but is some more equal than others? Tuberculosis in the digital era. (2020) Stagg, H. R., M. Flook, A. Martinecz, K. Kielmann, P. Abel Zur Wiesch, A. S. Karat, M. C. I. Lipman, D. J. Sloan, E. F. Walker and K. L. Fielding. ERJ Open Res 6(4) https://doi.org/10.1183/23120541.00315-2020

Analysis tools to quantify dissemination of pathology in zebrafish larvae. (2020) Stirling, D. R., O. Suleyman, E. Gil, P. M. Elks, V. Torraca, M. Noursadeghi and G. S. Tomlinson. Sci Rep 10(1): 3149 https://doi.org/10.1038/s41598-020-59932-1

Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes. (2020) Togun, T., B. Kampmann, N. G. Stoker and M. Lipman. Ann Clin Microbiol Antimicrob 19(1): 21 https://doi.org/10.1186/s12941-020-00363-1

Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-alpha. (2020) Tezera, L. B., M. K. Bielecka, P. Ogongo, N. F. Walker, M. Ellis, D. J. Garay-Baquero, K. Thomas, M. T. Reichmann, D. A. Johnston, K. A. Wilkinson, M. Ahmed, S. Jogai, S. N. Jayasinghe, R. J. Wilkinson, S. Mansour, G. J. Thomas, C. H. Ottensmeier, A. Leslie and P. T. Elkington. Elife 9 https://doi.org/10.7554/eLife.52668

Association between bacterial homoplastic variants and radiological pathology in tuberculosis. (2020) Grandjean, L., J. Monteserin, R. Gilman, J. Pauschardt, S. Rokadiya, C. Bonilla, V. Ritacco, J. R. Vidal, J. Parkhill, S. Peacock, D. A. Moore and F. Balloux. Thorax 75(7): 584-591 https://doi.org/10.1136/thoraxjnl-2019-213281

Bacille Calmette-Guerin (BCG) vaccine and the COVID-19 pandemic: Responsible stewardship is needed. (2020) Schaaf, H. S., K. du Preez, M. Kruger, R. Solomons, J. J. Taljaard, H. Rabie, J. A. Seddon, M. F. Cotton, M. Tebruegge, N. Curtis and A. C. Hesseling. Int J Tuberc Lung Dis 24(7): 732-734 https://doi.org/10.5588/ijtld.20.0267

Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients. (2020) Nimmo, C., J. Millard, K. Brien, S. Moodley, L. van Dorp, K. Lutchminarain, A. Wolf, A. D. Grant, F. Balloux, A. S. Pym, N. Padayatchi and M. O'Donnell. Eur Respir J 55(6) https://doi.org/10.1183/13993003.02383-2019

Bioactive compounds from the Bornean endemic plant Goniothalamus longistipetes. (2020) Teo, S. P., S. Bhakta, P. Stapleton and S. Gibbons. Antibiotics (Basel) 9(12) https://doi.org/10.3390/antibiotics9120913

Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study. (2020) Turner, C. T., R. K. Gupta, E. Tsaliki, J. K. Roe, P. Mondal, G. R. Nyawo, Z. Palmer, R. F. Miller, B. W. Reeve, G. Theron and M. Noursadeghi. Lancet Respir Med 8(4): 407-419 https://doi.org/10.1016/S2213-2600(19)30469-2

Blood transcriptomic stratification of short-term risk in contacts of tuberculosis. (2020) Roe, J., C. Venturini, R. K. Gupta, C. Gurry, B. M. Chain, Y. Sun, J. Southern, C. Jackson, M. C. Lipman, R. F. Miller, A. R. Martineau, I. Abubakar and M. Noursadeghi. Clin Infect Dis 70(5): 731-737 https://doi.org/10.1093/cid/ciz252

Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis. (2020) Maitra, A., D. Evangelopoulos, A. Chrzastek, L. T. Martin, A. Hanrath, E. Chapman, H. C. Hailes, M. Lipman, T. D. McHugh, S. J. Waddell and S. Bhakta. J Antimicrob Chemother 75(11): 3194-3201 https://doi.org/10.1093/jac/dkaa307

Chalcones, stilbenes and ketones have anti-infective properties via inhibition of bacterial drug-efflux and consequential synergism with antimicrobial agents. (2020) Hellewell, L. and S. Bhakta. Access Microbiol 2(4): acmi000105 https://doi.org/10.1099/acmi.0.000105

Chest pain and a left parasternal soft tissue swelling in an immunocompetent refugee with disseminated tuberculosis. (2020) Mondoni, M., M. Centola, O. Vigano, M. Ferrarese, L. Codecasa, A. D'Arminio Monforte, S. Carugo, S. Centanni, M. Lipman and G. Sotgiu. Int J Infect Dis 90: 116-118 https://doi.org/10.1016/j.ijid.2019.10.033

Clinical features and aetiology of cerebral palsy in children from Cross River State, Nigeria. (2020) Duke, R., C. Torty, K. Nwachukwu, S. Ameh, M. Kim, N. Eneli, A. Onyedikachi, A. Aghaji, K. Burton, L. Dyet and R. Bowman. Arch Dis Child 105(7): 625-630 https://doi.org/10.1136/archdischild-2019-317932

Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis-Report 1: Guidelines for initiating antitubercular therapy in tubercular choroiditis. (2020) Agrawal, R., I. Testi, S. Mahajan, Y. S. Yuen, A. Agarwal, O. M. Kon, T. Barisani-Asenbauer, J. H. Kempen, A. Gupta, D. A. Jabs, J. R. Smith, Q. D. Nguyen, C. Pavesio, V. Gupta and G. Collaborative Ocular Tuberculosis Study Consensus. Ophthalmology https://doi.org/10.1016/j.ophtha.2020.01.008

Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis-Report 2: Guidelines for initiating antitubercular therapy in anterior uveitis, intermediate uveitis, panuveitis, and retinal vasculitis. (2020) Agrawal, R., I. Testi, B. Bodaghi, T. Barisani-Asenbauer, P. McCluskey, A. Agarwal, J. H. Kempen, A. Gupta, J. R. Smith, M. D. de Smet, Y. S. Yuen, S. Mahajan, O. M. Kon, Q. D. Nguyen, C. Pavesio, V. Gupta and G. Collaborative Ocular Tuberculosis Study Consensus. Ophthalmology https://doi.org/10.1016/j.ophtha.2020.06.052

Comprehensive plasma proteomic profiling reveals biomarkers for active tuberculosis. (2020) Garay-Baquero, D. J., C. H. White, N. F. Walker, M. Tebruegge, H. F. Schiff, C. Ugarte-Gil, S. Morris-Jones, B. G. Marshall, A. Manousopoulou, J. Adamson, A. F. Vallejo, M. K. Bielecka, R. J. Wilkinson, L. B. Tezera, C. H. Woelk, S. D. Garbis and P. Elkington. JCI Insight 5(18) https://doi.org/10.1172/jci.insight.137427

Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis. (2020) Gupta, R. K., C. T. Turner, C. Venturini, H. Esmail, M. X. Rangaka, A. Copas, M. Lipman, I. Abubakar and M. Noursadeghi. Lancet Respir Med 8(4): 395-406 https://doi.org/10.1016/S2213-2600(19)30282-6

Contrasting inflammatory signatures in peripheral blood and bronchoalveolar cells reveal compartment-specific effects of HIV infection. (2020) Muema, D. M., M. Mthembu, A. E. Schiff, U. Singh, B. Corleis, D. Chen, T. Bassett, S. S. Rasehlo, K. Nyamande, D. F. Khan, P. Maharaj, M. Mitha, M. Suleman, Z. Mhlane, T. Naidoo, D. Ramjit, F. Karim, D. S. Kwon, T. Ndung'u and E. B. Wong. Front Immunol 11: 864 https://doi.org/10.3389/fimmu.2020.00864

A cost comparison of amikacin therapy with bedaquiline, for drug-resistant tuberculosis in the UK. (2020) Manalan, K., N. Green, A. Arnold, G. S. Cooke, M. Dedicoat, M. Lipman, A. Loyse, T. S. Harrison and O. M. Kon. J Infect 80(1): 38-41 https://doi.org/10.1016/j.jinf.2019.09.006

Cost effectiveness of testing HIV infected individuals for TB in a low TB/HIV setting. (2020) Capocci, S. J., J. Sewell, C. Smith, I. Cropley, S. Bhagani, A. Solamalai, S. Morris, I. Abubakar, M. A. Johnson and M. C. I. Lipman. J Infect 81(2): 289-296 https://doi.org/10.1016/j.jinf.2020.05.055

Cost-effectiveness of a novel lipoarabinomannan test for tuberculosis in patients with HIV. (2020) Reddy, K. P., C. M. Denkinger, T. Broger, N. C. McCann, A. Gupta-Wright, A. D. Kerkhoff, P. P. Pei, F. M. Shebl, K. L. Fielding, M. P. Nicol, C. R. Horsburgh, G. Meintjes, K. A. Freedberg, R. Wood and R. P. Walensky. Clin Infect Dis https://doi.org/10.1093/cid/ciaa1698

Coupling of peptidoglycan synthesis to central metabolism in mycobacteria: Post-transcriptional control of CwlM by aconitase. (2020) Bancroft, P. J., O. Turapov, H. Jagatia, K. B. Arnvig, G. V. Mukamolova and J. Green. Cell Rep 32(13): 108209 https://doi.org/10.1016/j.celrep.2020.108209

COVID-19 and tuberculosis-threats and opportunities. (2020) Zumla, A., B. J. Marais, T. D. McHugh, M. Maeurer, A. Zumla, N. Kapata, F. Ntoumi, P. Chanda-Kapata, S. Mfinanga, R. Centis, D. M. Cirillo, E. Petersen, D. S. Hui, G. Ippolito, C. C. Leung, G. B. Migliori and S. Tiberi. Int J Tuberc Lung Dis 24(8): 757-760 https://doi.org/10.5588/ijtld.20.0387

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. (2020) Gotzinger, F., B. Santiago-Garcia, A. Noguera-Julian, M. Lanaspa, L. Lancella, F. I. Calo Carducci, N. Gabrovska, S. Velizarova, P. Prunk, V. Osterman, U. Krivec, A. Lo Vecchio, D. Shingadia, A. Soriano-Arandes, S. Melendo, M. Lanari, L. Pierantoni, N. Wagner, A. G. L'Huillier, U. Heininger, N. Ritz, S. Bandi, N. Krajcar, S. Roglic, M. Santos, C. Christiaens, M. Creuven, D. Buonsenso, S. B. Welch, M. Bogyi, F. Brinkmann, M. Tebruegge and C.-S. G. ptbnet. Lancet Child Adolesc Health 4(9): 653-661 https://doi.org/10.1016/S2352-4642(20)30177-2

COVID-19 vaccine development: What lessons can we learn from TB? (2020) Safar, H. A., A. S. Mustafa and T. D. McHugh. Ann Clin Microbiol Antimicrob 19(1): 56 https://doi.org/10.1186/s12941-020-00402-x

Cross-transmission is not the source of new Mycobacterium abscessus infections in a multicenter cohort of cystic fibrosis patients. (2020) Doyle, R. M., M. Rubio, G. Dixon, J. Hartley, N. Klein, P. Coll and K. A. Harris. Clin Infect Dis 70(9): 1855-1864 https://doi.org/10.1093/cid/ciz526

Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK. (2020) Lipman, M., J. Cleverley, T. Fardon, B. Musaddaq, D. Peckham, R. van der Laan, P. Whitaker and J. White. BMJ Open Respir Res 7(1) https://doi.org/10.1136/bmjresp-2020-000591

Detecting tuberculosis in prisons: Switching off the disease at its source. (2020) Woodman, M. and L. Grandjean. Clin Infect Dis https://doi.org/10.1093/cid/ciaa139

Developing a pathway for the diagnosis and management of ocular tuberculosis. The pan-LOndon Ocular tuberculosis Pathway-LOOP. (2020) Petrushkin, H., C. Sethi, J. Potter, L. Martin, G. Russell, V. White, S. Ajamil-Rodanes, M. Brown, R. Breen, M. Lipman, I. Cropley, R. McDermott, A. Roche, H. Booth, J. Milburn, M. Darmalingam, R. Lee, C. Pavesio, M. Stanford, O. M. Kon and G. Bothamley. Eye (Lond) 34(5): 805-808 https://doi.org/10.1038/s41433-019-0543-7

Diagnostic accuracy of QuantiFERON-TB Gold Plus assays in children and adolescents with tuberculosis disease. (2020) Soler-Garcia, A., A. Gamell, B. Santiago, M. Monsonis, C. Calvo, E. Cobo, E. Colino, M. Espiau, C. Guerrero-Laleona, Z. Lobato, A. Martin-Nalda, B. Perez-Gorricho, T. M. Perez-Porcuna, A. I. Piqueras, P. Rodriguez-Molino, M. Ruiz, A. Soriano-Arandes, T. Valmanya, M. Tebruegge, A. Noguera-Julian and Q. F.-P. S. G. o. t. S. P. T. R. Network. J Pediatr 223: 212-215 e211 https://doi.org/10.1016/j.jpeds.2020.02.025

Diagnostic test accuracy of Xpert MTB/RIF for tuberculous pericarditis: a systematic review and meta-analysis. (2020) Andrianto, A., N. M. Mertaniasih, P. Gandi, M. J. Al-Farabi, Y. Azmi, M. Jonatan and S. I. Silahooij. F1000Res 9: 761 https://doi.org/10.12688/f1000research.22770.1

Diagnostic tests for tuberculous meningitis. (2020) Davis, A. G. and R. J. Wilkinson. Lancet Infect Dis 20(3): 262-263 https://doi.org/10.1016/S1473-3099(19)30718-2

Differential skewing of donor-unrestricted and gammadelta T cell repertoires in tuberculosis-infected human lungs. (2020) Ogongo, P., A. J. Steyn, F. Karim, K. J. Dullabh, I. Awala, R. Madansein, A. Leslie and S. M. Behar. J Clin Invest 130(1): 214-230 https://doi.org/10.1172/JCI130711

Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings. (2020) Gupta, R. K., C. J. Calderwood, A. Yavlinsky, M. Krutikov, M. Quartagno, M. C. Aichelburg, N. Altet, R. Diel, C. C. Dobler, J. Dominguez, J. S. Doyle, C. Erkens, S. Geis, P. Haldar, A. M. Hauri, T. Hermansen, J. C. Johnston, C. Lange, B. Lange, F. van Leth, L. Munoz, C. Roder, K. Romanowski, D. Roth, M. Sester, R. Sloot, G. Sotgiu, G. Woltmann, T. Yoshiyama, J. P. Zellweger, D. Zenner, R. W. Aldridge, A. Copas, M. X. Rangaka, M. Lipman, M. Noursadeghi and I. Abubakar. Nat Med 26(12): 1941-1949 https://doi.org/10.1038/s41591-020-1076-0

Drug misuse, tobacco smoking, alcohol and other social determinants of tuberculosis in UK-born adults in England: a community-based case-control study. (2020) Nguipdop-Djomo, P., L. C. Rodrigues, P. G. Smith, I. Abubakar and P. Mangtani. Sci Rep 10(1): 5639 https://doi.org/10.1038/s41598-020-62667-8

The DURATIONS randomised trial design: Estimation targets, analysis methods and operating characteristics. (2020) Quartagno, M., J. R. Carpenter, A. S. Walker, M. Clements and M. K. Parmar. Clin Trials 17(6): 644-653 https://doi.org/10.1177/1740774520944377

Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment. (2020) Nimmo, C., K. Brien, J. Millard, A. D. Grant, N. Padayatchi, A. S. Pym, M. O'Donnell, R. Goldstein, J. Breuer and F. Balloux. EBioMedicine 55: 102747 https://doi.org/10.1016/j.ebiom.2020.102747

Early or deferred initiation of efavirenz during rifampicin-based TB therapy has no significant effect on CYP3A induction in TB-HIV infected patients. (2020) Aklillu, E., A. Zumla, A. Habtewold, W. Amogne, E. Makonnen, G. Yimer, J. Burhenne and U. Diczfalusy. Br J Pharmacol https://doi.org/10.1111/bph.15309

Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial. (2020) Madan, J. J., L. Rosu, M. G. Tefera, C. van Rensburg, D. Evans, I. Langley, E. M. Tomeny, A. Nunn, P. P. Phillips, I. D. Rusen, S. B. Squire and S. s. h. e. e. collaborators. Bull World Health Organ 98(5): 306-314 https://doi.org/10.2471/BLT.19.243584

Edgar Leigh Collis: Industrial lung disease and ergonomics. (2020) Waldron, T. J Med Biogr 28(3): 157-162 https://doi.org/10.1177/0967772017735716

Effect of SARS-CoV-2 infection in pregnancy on maternal and neonatal outcomes in africa: an AFREhealth call for evidence through multicountry research collaboration. (2020) Nachega, J. B., N. A. Sam-Agudu, S. Budhram, T. E. Taha, V. Vannevel, P. Somapillay, D. K. Ishoso, M. Tshiasuma Pipo, C. Bongo-Pasi Nswe, J. Ditekemena, B. T. Ayele, R. N. Machekano, O. W. Gachuno, J. Kinuthia, N. Mwongeli, M. Sekikubo, P. Musoke, E. K. Agbeno, L. W. Umar, M. Ntakwinja, D. M. Mukwege, E. R. Smith, E. J. Mills, J. O. Otshudiema, P. Mbala-Kingebeni, J. N. Kayembe, D. J. Mavungu Landu, J. J. Muyembe Tamfum, A. Zumla, E. J. Langenegger, L. M. Mofenson and A. C.-R. C. W. G. For The. Am J Trop Med Hyg https://doi.org/10.4269/ajtmh.20-1553

Effectiveness of BCG vaccination against Mycobacterium tuberculosis infection in adults: A cross-sectional analysis of a UK-based cohort. (2020) Katelaris, A. L., C. Jackson, J. Southern, R. K. Gupta, F. Drobniewski, A. Lalvani, M. Lipman, P. Mangtani and I. Abubakar. J Infect Dis 221(1): 146-155 https://doi.org/10.1093/infdis/jiz430

Elevated N-terminal prohormone of brain natriuretic peptide among persons living with HIV in a South African peri-urban township. (2020) Peterson, T. E., J. V. Baker, L. Y. Wong, A. Rupert, N. A. B. Ntusi, H. Esmail, R. Wilkinson, I. Sereti, G. Meintjes, M. Ntsekhe and F. Thienemann. ESC Heart Fail 7(5): 3246-3251 https://doi.org/10.1002/ehf2.12849

Epidemic and pandemic viral infections: Impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). (2020) Ong, C. W. M., G. B. Migliori, M. Raviglione, G. MacGregor-Skinner, G. Sotgiu, J. W. Alffenaar, S. Tiberi, C. Adlhoch, T. Alonzi, S. Archuleta, S. Brusin, E. Cambau, M. R. Capobianchi, C. Castilletti, R. Centis, D. M. Cirillo, L. D'Ambrosio, G. Delogu, S. M. R. Esposito, J. Figueroa, J. S. Friedland, B. C. H. Ho, G. Ippolito, M. Jankovic, H. Y. Kim, S. Rosales Klintz, C. Kodmon, E. Lalle, Y. S. Leo, C. C. Leung, A. G. Martson, M. G. Melazzini, S. Najafi Fard, P. Penttinen, L. Petrone, E. Petruccioli, E. Pontali, L. Saderi, M. Santin, A. Spanevello, R. van Crevel, M. J. van der Werf, D. Visca, M. Viveiros, J. P. Zellweger, A. Zumla and D. Goletti. Eur Respir J 56(4) https://doi.org/10.1183/13993003.01727-2020

Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution. (2020) Gonzalo, X., G. Satta, J. Ortiz Canseco, T. D. McHugh and F. Drobniewski. BMC Microbiol 20(1): 271 https://doi.org/10.1186/s12866-020-01954-w

Ethambutol disposition in humans: Challenges and limitations of whole-body physiologically-based pharmacokinetic modelling in early drug development. (2020) Carrara, L., P. Magni, D. Teutonico, L. Pasotti, O. Della Pasqua and F. Kloprogge. Eur J Pharm Sci 150: 105359 https://doi.org/10.1016/j.ejps.2020.105359

Evaluation of pharmacokinetic-pharmacodynamic relationships and selection of drug combinations for tuberculosis. (2021) Muliaditan, M. and O. Della Pasqua. Br J Clin Pharmacol 87(1): 140-151 https://doi.org/10.1111/bcp.14371

Exposure to waste sites and their impact on health: a panel and geospatial analysis of nationally representative data from South Africa, 2008-2015. (2020) Tomita, A., D. F. Cuadros, J. K. Burns, F. Tanser and R. Slotow. Lancet Planet Health 4(6): e223-e234 https://doi.org/10.1016/S2542-5196(20)30101-7

HARP: a database of structural impacts of systematic missense mutations in drug targets of Mycobacterium leprae. (2020) Vedithi, S. C., S. Malhotra, M. J. Skwark, A. Munir, M. Acebron-Garcia-De-Eulate, V. P. Waman, A. Alsulami, D. B. Ascher and T. L. Blundell. Comput Struct Biotechnol J 18: 3692-3704 https://doi.org/10.1016/j.csbj.2020.11.013

Healthcare delivery for HIV-positive people with tuberculosis in Europe. (2020) Bentzon, A. K., A. Panteleev, V. Mitsura, E. Borodulina, A. Skrahina, E. Denisova, S. Tetradov, R. Podlasin, V. Riekstina, Z. Kancauskiene, D. Paduto, A. Mocroft, T. Trofimova, R. Miller, F. Post, A. Grezesczuk, J. D. Lundgren, M. Inglot, D. Podlekareva, N. Bolokadze, O. Kirk and T. H. S. Group. HIV Med https://doi.org/10.1111/hiv.13016

Host-directed therapies and holistic care for tuberculosis. (2020) Zumla, A., G. Ippolito, F. Ntoumi, V. Seyfert-Margolies, T. J. Nagu, D. Cirillo, J. M. Chakaya, B. Marais and M. Maeurer. Lancet Respir Med 8(4): 337-340 https://doi.org/10.1016/S2213-2600(20)30078-3

Immunometabolism: new insights and lessons from antigen-directed cellular immune responses. (2020) Ramalho, R., M. Rao, C. Zhang, C. Agrati, G. Ippolito, F. S. Wang, A. Zumla and M. Maeurer. Semin Immunopathol 42(3): 279-313 https://doi.org/10.1007/s00281-020-00798-w

Impact of baseline tuberculin skin test and isoniazid chemoprophylaxis on subsequent Quantiferon-TB Gold in-tube performance in young children assessed after tuberculosis contact in Catalonia. (2020) Velasco-Arnaiz, E., A. Soriano-Arandes, M. Espiau, N. Altet, C. Fortuny, M. Monsonis, M. Tebruegge and A. Noguera-Julian. Pediatr Infect Dis J 39(2): e22-e25 https://doi.org/10.1097/INF.0000000000002517

The impact of HIV infection on tuberculosis transmission in a country with low tuberculosis incidence: a national retrospective study using molecular epidemiology. (2020) Winter, J. R., C. J. Smith, J. A. Davidson, M. K. Lalor, V. Delpech, I. Abubakar and H. R. Stagg. BMC Med 18(1): 385 https://doi.org/10.1186/s12916-020-01849-7

Implementation of routine interferon-gamma release assay testing in a South London HIV cohort. (2020) Sandhu, P., C. Taylor, R. F. Miller and F. A. Post. Int J STD AIDS 31(3): 264-267 https://doi.org/10.1177/0956462419893536

Improved treatment completion for tuberculosis patients: The case for a dedicated social care team. (2020) Izzard, A., S. Wilders, C. Smith, M. Wickers, T. Hart, J. Dos Santos, H. Booth, D. Creer, I. Cropley, S. Lozewicz, J. White and M. Lipman. J Infect https://doi.org/10.1016/j.jinf.2020.12.019

Improving access to contraception through integration of family planning services into a multidrug-resistant tuberculosis treatment programme. (2020) Cornish, E. F., J. Hudson, R. Sayers and M. Loveday. BMJ Sex Reprod Health 46(2): 152-155 https://doi.org/10.1136/bmjsrh-2019-200400

Improving the potency of N-Aryl-2,5-dimethylpyrroles against multidrug-resistant and intracellular mycobacteria. (2020) Touitou, M., F. Manetti, C. M. Ribeiro, F. R. Pavan, N. Scalacci, K. Zrebna, N. Begum, D. Semenya, A. Gupta, S. Bhakta, T. D. McHugh, H. Senderowitz, M. Kyriazi and D. Castagnolo. ACS Med Chem Lett 11(5): 638-644 https://doi.org/10.1021/acsmedchemlett.9b00515

In reference to the management of nontuberculous mycobacterial cervicofacial lymphadenitis: A view beyond surgery. (2020) Zimmermann, P., N. Ritz, N. Curtis and M. Tebruegge. Laryngoscope 130(12): E945-E946 https://doi.org/10.1002/lary.28608

Incidence of and risk factors for tuberculosis among people with HIV on antiretroviral therapy in the United Kingdom. (2020) van Halsema, C. L., H. Okhai, T. Hill, C. A. Sabin and U. K. C. H. C. Study. AIDS 34(12): 1813-1821 https://doi.org/10.1097/QAD.0000000000002599

Increased neutrophil count and decreased neutrophil CD15 expression correlate with TB disease severity and treatment response irrespective of HIV co-infection. (2020) Ndlovu, L. N., L. Peetluk, S. Moodley, S. Nhamoyebonde, A. T. Ngoepe, M. Mazibuko, K. Khan, F. Karim, A. S. Pym, F. Maruri, M. S. Moosa, Y. F. van der Heijden, T. R. Sterling and A. Leslie. Front Immunol 11: 1872 https://doi.org/10.3389/fimmu.2020.01872

Integrated screening of migrants for multiple infectious diseases: Qualitative study of a city-wide programme. (2020) Eborall, H., F. Wobi, K. Ellis, J. Willars, I. Abubakar, C. Griffiths and M. Pareek. EClinicalMedicine 21: 100315 https://doi.org/10.1016/j.eclinm.2020.100315

Intervening along the spectrum of tuberculosis: meeting report from the World TB Day nanosymposium in the Institute of Infectious Disease and Molecular Medicine at the University of Cape Town. (2019) Hadebe, S., M. Chengalroyen, R. Guler, K. Nakedi, A. Koch, M. Makatsa, M. Shey, S. P. Parihar, B. Bryson, M. J. Marakalala and H. Ndlovu. Gates Open Res 3: 1491 https://doi.org/10.12688/gatesopenres.13035.4

A Journey of Hope: giving research participants a voice to share their experiences and improve community engagement around advanced HIV disease in Uganda. (2020) Cresswell, F. V., J. Kasibante, E. M. Martyn, L. Tugume, G. Stead, K. Ssembambulidde, M. K. Rutakingirwa, E. Kagimu, L. Nsangi, C. Namuju, J. F. Ndyetukira, C. Ahimbisibwe, F. Kugonza, A. Sadiq, A. Namudde, J. Dobbin, D. Srishyla, C. Quinn, M. Kabahubya, C. Muzoora, S. Watiti, D. B. Meya and A. M. Elliott. AAS Open Res 3: 33 https://doi.org/10.12688/aasopenres.13104.2

Knowledge, attitudes, and behaviors on utilizing mobile health technology for TB in Indonesia: A qualitative pilot study. (2020) Aisyah, D. N., R. A. Ahmad, W. T. Artama, W. Adisasmito, H. Diva, A. C. Hayward and Z. Kozlakidis. Front Public Health 8: 531514 https://doi.org/10.3389/fpubh.2020.531514

Latent tuberculosis infection screening and treatment in congregate settings (TB FREE COREA): protocol for a prospective observational study in Korea. (2020) Min, J., H. W. Kim, H. R. Stagg, M. Lipman, M. X. Rangaka, J. P. Myong, H. W. Yim, J. U. Lim, Y. Lee, H. K. Koo, S. S. Lee, J. S. Park, K. S. Cho and J. S. Kim. BMJ Open 10(2): e034098 https://doi.org/10.1136/bmjopen-2019-034098

Longitudinal pharmacokinetic-pharmacodynamic biomarkers correlate with treatment outcome in drug-sensitive pulmonary tuberculosis: A population pharmacokinetic-pharmacodynamic analysis. (2020) Kloprogge, F., H. C. Mwandumba, G. Banda, M. Kamdolozi, D. Shani, E. L. Corbett, N. Kontogianni, S. Ward, S. H. Khoo, G. R. Davies and D. J. Sloan. Open Forum Infect Dis 7(7): ofaa218 https://doi.org/10.1093/ofid/ofaa218

Management and control of tuberculosis control in socially complex groups: a research programme including three RCTs. (2020) Story, A., E. Garber, R. W. Aldridge, C. M. Smith, J. Hall, G. Ferenando, L. Possas, S. Hemming, F. Wurie, S. Luchenski, I. Abubakar, T. D. McHugh, P. J. White, J. M. Watson, M. Lipman, R. Garfein and A. C. Hayward. Programme Grants for Applied Research 8(9) https://doi.org/http://doi.org/10.3310/pgfar08090

Management of HIV-infected patients in the intensive care unit. (2020) Barbier, F., M. Mer, P. Szychowiak, R. F. Miller, E. Mariotte, L. Galicier, L. Bouadma, P. Tattevin and E. Azoulay. Intensive Care Med 46(2): 329-342 https://doi.org/10.1007/s00134-020-05945-3

MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. (2020) Migliori, G. B., S. Tiberi, A. Zumla, E. Petersen, J. M. Chakaya, C. Wejse, M. Munoz Torrico, R. Duarte, J. W. Alffenaar, H. S. Schaaf, B. J. Marais, D. M. Cirillo, R. Alagna, A. Rendon, E. Pontali, A. Piubello, J. Figueroa, G. Ferlazzo, A. Garcia-Basteiro, R. Centis, D. Visca, L. D'Ambrosio, G. Sotgiu and N. members of the Global Tuberculosis. Int J Infect Dis 92S: S15-S25 https://doi.org/10.1016/j.ijid.2020.01.042

Measuring and reporting treatment adherence: What can we learn by comparing two respiratory conditions? (2020) Tibble, H., M. Flook, A. Sheikh, A. Tsanas, R. Horne, B. Vrijens, S. De Geest and H. R. Stagg. Br J Clin Pharmacol https://doi.org/10.1111/bcp.14458

Missing men with tuberculosis: the need to address structural influences and implement targeted and multidimensional interventions. (2020) Chikovore, J., M. Pai, K. C. Horton, A. Daftary, M. K. Kumwenda, G. Hart and E. L. Corbett. BMJ Glob Health 5(5) https://doi.org/10.1136/bmjgh-2019-002255

Mitochondrial Signature in Human Monocytes and Resistance to Infection in C. elegans During Fumarate-Induced Innate Immune Training. (2020) Perez-Hernandez, C. A., C. C. Kern, E. Butkeviciute, E. McCarthy, H. M. Dockrell, M. M. B. Moreno-Altamirano, B. A. Aguilar-Lopez, G. Bhosale, H. Wang, D. Gems, M. R. Duchen, S. G. Smith and F. J. Sanchez-Garcia. Front Immunol 11: 1715 https://doi.org/10.3389/fimmu.2020.01715

A model of tuberculosis clustering in low incidence countries reveals more transmission in the United Kingdom than the Netherlands between 2010 and 2015. (2020) Brooks-Pollock, E., L. Danon, H. Korthals Altes, J. A. Davidson, A. M. T. Pollock, D. van Soolingen, C. Campbell and M. K. Lalor. PLoS Comput Biol 16(3): e1007687 https://doi.org/10.1371/journal.pcbi.1007687

Mycobacterial immunotherapy for prostate cancer: where can we go from here? (2020) Stavrinides, V., A. Dalgleish, J. P. Copier and C. M. Moore. Nat Rev Urol 17(4): 189-190 https://doi.org/10.1038/s41585-020-0283-2

Mycobacterium ulcerans-specific immune response after immunisation with bacillus Calmette-Guerin (BCG) vaccine. (2021) Pittet, L. F., M. Tebruegge, B. Dutta, S. Donath, N. Messina, D. Casalaz, W. A. Hanekom, W. J. Britton, R. Robins-Browne, N. Curtis, N. Ritz and B. C. G. I. R. S. group. Vaccine 39(4): 652-657 https://doi.org/10.1016/j.vaccine.2020.11.045

The NHS visitor and migrant cost recovery programme - a threat to health? (2020) Potter, J. L., M. Burman, C. D. Tweed, D. Vaghela, H. Kunst, D. Swinglehurst and C. J. Griffiths. BMC Public Health 20(1): 407 https://doi.org/10.1186/s12889-020-08524-9

NIX-mediated mitophagy regulate metabolic reprogramming in phagocytic cells during mycobacterial infection. (2020) Mahla, R. S., A. Kumar, H. J. Tutill, S. T. Krishnaji, B. Sathyamoorthy, M. Noursadeghi, J. Breuer, A. K. Pandey and H. Kumar. Tuberculosis (Edinb) 126: 102046 https://doi.org/10.1016/j.tube.2020.102046

Oldest evidence of tuberculosis in Argentina: A multidisciplinary investigation in an adult male skeleton from Saujil, Tinogasta, Catamarca (905-1030 CE). (2020) Luna, L. H., C. M. Aranda, A. L. Santos, H. D. Donoghue, O. Y. Lee, H. H. T. Wu, G. S. Besra, D. E. Minnikin, G. Llewellyn, C. M. Williams and N. Ratto. Tuberculosis (Edinb) 125: 101995 https://doi.org/10.1016/j.tube.2020.101995

Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. (2020) Meghji, J., M. Lesosky, E. Joekes, P. Banda, J. Rylance, S. Gordon, J. Jacob, H. Zonderland, P. MacPherson, E. L. Corbett, K. Mortimer and S. B. Squire. Thorax 75(3): 269-278 https://doi.org/10.1136/thoraxjnl-2019-213808

Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study. (2020) Basu Roy, R., S. Thee, D. Blazquez-Gamero, L. Falcon-Neyra, O. Neth, A. Noguera-Julian, C. Lillo, L. Galli, E. Venturini, D. Buonsenso, F. Gotzinger, N. Martinez-Alier, S. Velizarova, F. Brinkmann, S. B. Welch, M. Tsolia, B. Santiago-Garcia, R. Kruger, M. Tebruegge and T. B. M. S. G. ptbnet. Eur Respir J 56(1) https://doi.org/10.1183/13993003.02004-2019

PET/CT features of extrapulmonary tuberculosis at first clinical presentation: A cross-sectional observational (18)F-FDG imaging study across six countries. (2020) Bomanji, J., R. Sharma, B. R. Mittal, S. Gambhir, A. Qureshy, S. M. F. Begum, D. Paez, M. Sathekge, M. Vorster, D. Sobic Saranovic, P. Pusuwan, V. Mann, S. Vinjamuri, A. Zumla, T. N. B. Pascual and T. B. C. International Atomic Energy Agency Extra-pulmonary. Eur Respir J 55(2) https://doi.org/10.1183/13993003.01959-2019

Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review. (2020) Jacobs, T. G., E. M. Svensson, V. Musiime, P. Rojo, K. E. Dooley, H. McIlleron, R. E. Aarnoutse, D. M. Burger, A. Turkova, A. Colbers and W. H. O. P. A. W. Group. J Antimicrob Chemother 75(12): 3433-3457 https://doi.org/10.1093/jac/dkaa328

Polymersomes eradicating intracellular bacteria. (2020) Fenaroli, F., J. D. Robertson, E. Scarpa, V. M. Gouveia, C. Di Guglielmo, C. De Pace, P. M. Elks, A. Poma, D. Evangelopoulos, J. O. Canseco, T. K. Prajsnar, H. M. Marriott, D. H. Dockrell, S. J. Foster, T. D. McHugh, S. A. Renshaw, J. S. Marti, G. Battaglia and L. Rizzello. ACS Nano 14(7): 8287-8298 https://doi.org/10.1021/acsnano.0c01870

Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis. (2020) Nimmo, C., J. Millard, L. van Dorp, K. Brien, S. Moodley, A. Wolf, A. D. Grant, N. Padayatchi, A. S. Pym, F. Balloux and M. O'Donnell. Lancet Microbe 1(4): e165-e174 https://doi.org/10.1016/S2666-5247(20)30031-8

Post tuberculosis treatment infectious complications. (2020) Hsu, D., M. Irfan, K. Jabeen, N. Iqbal, R. Hasan, G. B. Migliori, A. Zumla, D. Visca, R. Centis and S. Tiberi. Int J Infect Dis 92S: S41-S45 https://doi.org/10.1016/j.ijid.2020.02.032

A postgraduate qualification in tuberculosis-Message in a bottle. (2020) Tiberi, S., A. Zumla, M. Raviglione, M. Lipman, O. M. Kon, C. Griffiths and G. B. Migliori. Int J Infect Dis 92S: S100-S102 https://doi.org/10.1016/j.ijid.2020.02.023

Predictive performance of interferon-gamma release assays and tuberculin skin tests. (2020) Hamada, Y., R. K. Gupta, A. Matteelli, I. Abubakar and M. X. Rangaka. Lancet Infect Dis 20(12): 1371-1372 https://doi.org/10.1016/S1473-3099(20)30772-6

Premature mortality attributable to socioeconomic inequality in England between 2003 and 2018: an observational study. (2020) Lewer, D., W. Jayatunga, R. W. Aldridge, C. Edge, M. Marmot, A. Story and A. Hayward. Lancet Public Health 5(1): e33-e41 https://doi.org/10.1016/S2468-2667(19)30219-1

Preventing tuberculosis in paediatric kidney transplant recipients: is there a role for BCG immunisation pre-transplantation in low tuberculosis incidence countries? (2020) Bamford, A., G. Dixon, N. Klein, S. D. Marks, N. Ritz, S. B. Welch and M. Tebruegge. Pediatr Nephrol https://doi.org/10.1007/s00467-020-04844-5

Primary urethral tuberculosis with urethrocutaneous fistula in association with balanitis xerotica obliterans. (2020) Mukherjee, S., R. K. Sinha, S. N. Mandal and W. S. Tan. Urology 141: e20-e21 https://doi.org/10.1016/j.urology.2020.04.035

Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis. (2020) Chakaya, J. M., B. Marais, P. du Cros, F. Ntoumi, S. Mfinanga, N. Kapata, S. E. Hasnain, R. Nathavitharana and A. Zumla. Lancet Respir Med 8(4): 334-335 https://doi.org/10.1016/S2213-2600(20)30104-1

Protocol for a systematic review of treatment adherence for HIV, hepatitis C and tuberculosis among homeless populations. (2020) Johnson, L., D. Lewer, R. W. Aldridge, A. C. Hayward and A. Story. Syst Rev 9(1): 211 https://doi.org/10.1186/s13643-020-01470-y

Protocol: Leveraging a demographic and health surveillance system for Covid-19 Surveillance in rural KwaZulu-Natal. (2020) Siedner, M. J., G. Harling, A. Derache, T. Smit, T. Khoza, R. Gunda, T. Mngomezulu, D. Gareta, N. Majozi, E. Ehlers, J. Dreyer, S. Nxumalo, N. Dayi, G. Ording-Jesperson, N. Ngwenya, E. Wong, C. Iwuji, M. Shahmanesh, J. Seeley, T. De Oliveira, T. Ndung'u, W. Hanekom and K. Herbst. Wellcome Open Res 5: 109 https://doi.org/10.12688/wellcomeopenres.15949.2

Quantitative IFN-gamma release assay and tuberculin skin test results to predict incident tuberculosis. A prospective cohort study. (2020) Gupta, R. K., M. Lipman, C. Jackson, A. J. Sitch, J. Southern, F. Drobniewski, J. J. Deeks, C. Y. Tsou, C. Griffiths, J. Davidson, C. Campbell, O. Stirrup, M. Noursadeghi, H. Kunst, P. Haldar, A. Lalvani and I. Abubakar. Am J Respir Crit Care Med 201(8): 984-991 https://doi.org/10.1164/rccm.201905-0969OC

Recent developments in tuberculous meningitis pathogenesis and diagnostics. (2019) Cresswell, F. V., A. G. Davis, K. Sharma, R. Basu Roy, A. R. Ganiem, E. Kagimu, R. Solomons, R. J. Wilkinson, N. C. Bahr, N. T. T. Thuong and C. Tuberculous Meningitis International Research. Wellcome Open Res 4: 164 https://doi.org/10.12688/wellcomeopenres.15506.2

The relationship between social risk factors and latent tuberculosis infection among individuals residing in England: a cross-sectional study. (2020) Lule, S. A., R. K. Gupta, M. Krutikov, C. Jackson, J. Southern and I. Abubakar. BMJ Glob Health 5(12) https://doi.org/10.1136/bmjgh-2020-003550

Reply. (2020) Agrawal, R., A. Agarwal, I. Testi, S. Mahajan, Y. S. Yuen, A. Rousselot, Q. D. Nguyen, C. Pavesio and V. Gupta. Ophthalmology 127(11): e102-e103 https://doi.org/10.1016/j.ophtha.2020.06.005

A retrospective study on the risk of tuberculosis in patients with rheumatoid arthritis. (2020) Chung, T. T., H. J. Ko, C. S. Lau and H. Y. Chung. Rheumatol Int 40(6): 983-990 https://doi.org/10.1007/s00296-020-04583-8

Role of pharmacogenetics in rifampicin pharmacokinetics and the potential effect on TB-rifampicin sensitivity among Ugandan patients. (2020) Mukonzo, J. K., A. Kengo, B. Kutesa, S. Nanzigu, A. Pohanka, T. D. McHugh, A. Zumla and E. Aklillu. Trans R Soc Trop Med Hyg 114(2): 107-114 https://doi.org/10.1093/trstmh/trz108

Role of whole-genome sequencing in characterizing the mechanism of action of para-aminosalicylic acid and its resistance. (2020) Satta, G., A. A. Witney, N. Begum, J. Ortiz Canseco, A. N. Boa and T. D. McHugh. Antimicrob Agents Chemother 64(9) https://doi.org/10.1128/AAC.00675-20

Screening for infection in unaccompanied asylum-seeking children and young people. (2020) Williams, B., M. Boullier, Z. Cricks, A. Ward, R. Naidoo, A. Williams, K. Robinson, S. Eisen and J. Cohen. Arch Dis Child 105(6): 530-532 https://doi.org/10.1136/archdischild-2019-318077

Sequential (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) scan findings in patients with extrapulmonary tuberculosis during the course of treatment-a prospective observational study. (2020) Bomanji, J., R. Sharma, B. R. Mittal, S. Gambhir, A. Qureshy, S. M. F. Begum, D. Paez, M. Sathekge, M. Vorster, D. Sobic Saranovic, P. Pusuwan, V. Mann, S. Vinjamuri, A. Zumla and T. N. B. Pascual. Eur J Nucl Med Mol Imaging 47(13): 3118-3129 https://doi.org/10.1007/s00259-020-04888-7

Small-area level socio-economic deprivation and tuberculosis rates in England: An ecological analysis of tuberculosis notifications between 2008 and 2012. (2020) Nguipdop-Djomo, P., L. C. Rodrigues, I. Abubakar and P. Mangtani. PLoS One 15(10): e0240879 https://doi.org/10.1371/journal.pone.0240879

Subclinical tuberculosis disease - a review and analysis of prevalence surveys to inform definitions, burden, associations and screening methodology. (2020) Frascella, B., A. S. Richards, B. Sossen, J. C. Emery, A. Odone, I. Law, I. Onozaki, H. Esmail and R. Houben. Clin Infect Dis https://doi.org/10.1093/cid/ciaa1402

Synthesis and biological Evaluation of a Novel C8-pyrrolobenzodiazepine (PBD) adenosine conjugate. A study on the role of the PBD ring in the biological activity of PBD-conjugates. (2020) Ferguson, L., S. Bhakta, K. R. Fox, G. Wells and F. Brucoli. Molecules 25(5) https://doi.org/10.3390/molecules25051243

A systematic review of the impact of psychosocial factors on immunity: Implications for enhancing BCG response against tuberculosis. (2020) Hayward, S. E., J. B. Dowd, H. Fletcher, L. B. Nellums, F. Wurie and D. Boccia. SSM Popul Health 10: 100522 https://doi.org/10.1016/j.ssmph.2019.100522

Tackling long-term morbidity and mortality after successful tuberculosis treatment. (2020) Marais, B. J., J. Chakaya, S. Swaminathan, G. J. Fox, N. Z. Ehtesham, F. Ntoumi, L. Zijenah, M. Maurer and A. Zumla. Lancet Infect Dis 20(6): 641-642 https://doi.org/10.1016/S1473-3099(20)30167-5

Test evaluation trials present different challenges for trial managers compared to intervention trials. (2020) Rick, C., S. Mallett, J. Brown, R. Ottridge, A. Palmer, V. Parker, L. Priest and J. J. Deeks. Trials 21(1): 987 https://doi.org/10.1186/s13063-020-04861-7

A threat to decentralised care for drug-resistant tuberculosis. (2020) Gray, A. T., T. Boyles, S. Luedtke, B. Sossen, G. Birjovanu, P. Kostkova, J. Hughes and H. Esmail. Lancet Respir Med 8(10): 950-952 https://doi.org/10.1016/S2213-2600(20)30392-1

Three-dimensional in situ morphometrics of Mycobacterium tuberculosis infection within lesions by optical mesoscopy and novel acid-fast staining. (2020) Francis, R. J., G. Robb, L. McCann, B. Khatri, J. Keeble, B. Dagg, B. Amos, F. J. Salguero, M. M. Ho, A. Bullen, G. McConnell and K. MacLellan-Gibson. Sci Rep 10(1): 21774 https://doi.org/10.1038/s41598-020-78640-4

Towards more accurate (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) imaging in active and latent tuberculosis. (2020) Priftakis, D., S. Riaz, A. Zumla and J. Bomanji. Int J Infect Dis 92S: S85-S90 https://doi.org/10.1016/j.ijid.2020.02.017

Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations. (2020) Esmail, H., F. Cobelens and D. Goletti. Eur Respir J 55(3) https://doi.org/10.1183/13993003.01957-2019

Transmission analysis of a large tuberculosis outbreak in London: a mathematical modelling study using genomic data. (2020) Xu, Y., J. E. Stockdale, V. Naidu, H. Hatherell, J. Stimson, H. R. Stagg, I. Abubakar and C. Colijn. Microb Genom 6(11) https://doi.org/10.1099/mgen.0.000450

Transmission of respiratory tract infections at mass gathering events. (2020) Petersen, E., Z. A. Memish, A. Zumla and A. A. Maani. Curr Opin Pulm Med 26(3): 197-202 https://doi.org/10.1097/MCP.0000000000000675

Treatment of highly drug-resistant pulmonary tuberculosis. (2020) Conradie, F., A. H. Diacon, N. Ngubane, P. Howell, D. Everitt, A. M. Crook, C. M. Mendel, E. Egizi, J. Moreira, J. Timm, T. D. McHugh, G. H. Wills, A. Bateson, R. Hunt, C. Van Niekerk, M. Li, M. Olugbosi, M. Spigelman and T. B. T. T. Nix. N Engl J Med 382(10): 893-902 https://doi.org/10.1056/NEJMoa1901814

Treatment of highly drug-resistant pulmonary tuberculosis. (2020) Nimmo, C., K. Naidoo and M. O'Donnell. N Engl J Med 382(24): 2376 https://doi.org/10.1056/NEJMc2009939

Treatment of highly drug-resistant pulmonary tuberculosis. Reply. (2020) Conradie, F., D. Everitt and A. M. Crook. N Engl J Med 382(24): 2377 https://doi.org/10.1056/NEJMc2009939

Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis Molecular Bacterial Load Assay. (2020) Sabiiti, W., K. Azam, E. C. W. Farmer, D. Kuchaka, B. Mtafya, R. Bowness, K. Oravcova, I. Honeyborne, D. Evangelopoulos, T. D. McHugh, C. Khosa, A. Rachow, N. Heinrich, E. Kampira, G. Davies, N. Bhatt, E. N. Ntinginya, S. Viegas, I. Jani, M. Kamdolozi, A. Mdolo, M. Khonga, M. J. Boeree, P. P. J. Phillips, D. Sloan, M. Hoelscher, G. Kibiki and S. H. Gillespie. Thorax 75(7): 606-608 https://doi.org/10.1136/thoraxjnl-2019-214238

Tuberculosis disease in children and adolescents on therapy with antitumor necrosis factor-a agents: A collaborative, multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) study. (2020) Noguera-Julian, A., J. Calzada-Hernandez, F. Brinkmann, R. Basu Roy, O. Bilogortseva, M. Buettcher, I. Carvalho, V. Chechenyeva, L. Falcon, F. Goetzinger, C. Guerrero-Laleona, P. Hoffmann, M. Jelusic, T. Niehues, I. Ozere, F. Shackley, E. Suciliene, S. B. Welch, E. H. Scholvinck, N. Ritz and M. Tebruegge. Clin Infect Dis 71(10): 2561-2569 https://doi.org/10.1093/cid/ciz1138

Tuberculosis from transmission in clinics in high HIV settings may be far higher than contact data suggest. (2020) McCreesh, N., A. D. Grant, T. A. Yates, A. S. Karat and R. G. White. Int J Tuberc Lung Dis 24(4): 403-408 https://doi.org/10.5588/ijtld.19.0410

Tuberculosis in children, adolescents, and women. (2020) Marais, B. J., F. Amanullah, A. Gupta, M. C. Becerra, K. Snow, E. Ngadaya, M. Sharma, A. C. Hesseling, M. Chakaya and A. Zumla. Lancet Respir Med 8(4): 335-337 https://doi.org/10.1016/S2213-2600(20)30077-1

Tuberculosis-HIV co-infection: progress and challenges after two decades of global antiretroviral treatment roll-out. (2020) Letang, E., J. Ellis, K. Naidoo, E. C. Casas, P. Sanchez, R. Hassan-Moosa, F. Cresswell, J. M. Miro and A. L. Garcia-Basteiro. Arch Bronconeumol 56(7): 446-454 https://doi.org/10.1016/j.arbres.2019.11.015

UN General Assembly tuberculosis targets: are we on track? (2020) Sahu, S., L. Ditiu, L. Lawson, F. Ntoumi, D. Arakaki and A. Zumla. Lancet 395(10228): 928-930 https://doi.org/10.1016/S0140-6736(20)30565-1

A user-centred design framework for mHealth. (2020) Farao, J., B. Malila, N. Conrad, T. Mutsvangwa, M. X. Rangaka and T. S. Douglas. PLoS One 15(8): e0237910 https://doi.org/10.1371/journal.pone.0237910

Verification of tuberculosis infection among Vac mummies (18th century CE, Hungary) based on lipid biomarker profiling with a new HPLC-HESI-MS approach. (2020) Varadi, O. A., D. Rakk, O. Spekker, G. Terhes, E. Urban, W. Berthon, I. Pap, I. Szikossy, F. Maixner, A. Zink, C. Vagvolgyi, H. D. Donoghue, D. E. Minnikin, A. Szekeres and G. Palfi. Tuberculosis (Edinb) 126: 102037 https://doi.org/10.1016/j.tube.2020.102037

Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study. (2020) Gupta-Wright, A., K. Fielding, J. J. van Oosterhout, M. Alufandika, D. J. Grint, E. Chimbayo, J. Heaney, M. Byott, E. Nastouli, H. C. Mwandumba, E. L. Corbett and R. K. Gupta. Lancet HIV 7(9): e620-e628 https://doi.org/10.1016/S2352-3018(20)30172-7

Zoonotic tuberculosis-a call for an open One Health debate. (2020) Zumla, A., D. Yeboah-Manu, A. L. Michel, E. I. Azhar, J. B. Torrelles, S. I. Cadmus, S. L. Kendall, J. M. Chakaya, B. Marais and R. Kock. Lancet Infect Dis 20(6): 642-644 https://doi.org/10.1016/S1473-3099(20)30166-3

Other Outputs

TB and COVID-19 discussion  (https://www.ucl.ac.uk/tb/how-will-covid-19-affect-tb-patients-and-control)

The IMPACT study - Voices from the Front Line 24 mar2020 (https://www.ucl.ac.uk/tb/impact-study)

Blog: JoiHok!: New UCL graduate sets up TB initiative in Kolkata (https://blogs.ucl.ac.uk/tb/2020/03/30/joihok/)

Back to top